Despite being part of recommended algorithms for the differential diagnosis of TMA [1, 10] only two-thirds of respondents agreed that an ADAMTS13 activity >10% rules out TTP. This evidence concerns the gene ADAMTS13 and thrombotic thrombocytopenic purpura.